Jan Trøst Jørgensen

HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature

Jan Trøst Jørgensen, Maria Hersom · Journal of Cancer · 2012 · 286 citations · Full text

Medicine, Oncology, Pathology +16

Targeted HER2 Treatment in Advanced Gastric Cancer

Jan Trøst Jørgensen · Oncology · 2010 · 145 citations

Medicine, Oncology, Pharmacology +14

The value of<i>TOP2A</i>gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D

Kirsten Vang Nielsen, Bent Ejlertsen, Susanne Möller et al. · Acta Oncologica · 2008 · 111 citations · Full text

Medicine, Cancer Biology, Oncology +16

Digital X‐ray radiogrammetry: a new appendicular bone densitometric method with high precision

Jan Trøst Jørgensen, P. B. Andersen, Anders Rosholm et al. · Clinical Physiology · 2000 · 106 citations

Medicine, Radiology, Bone Metabolism +16

Pain Assessment of Subcutaneous Injections

Jan Trøst Jørgensen, Jørn Møller Sonnergaard, L.P. Vang · Annals of Pharmacotherapy · 1996 · 81 citations

Nursing, Pharmacology, Pain Management +15